Remove Dermatitis Remove Eczema Remove Pharmaceutical
article thumbnail

Oh, The Places Dermatology Will Go in 2024!

The Dermatology Digest

Dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc., Peter Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, agrees that it is going to be a big year for eczema patients and the doctors who treat them. “I

article thumbnail

Label Update: FDA Green Lights Dupilumab for AD Patients With Moderate-to-Severe Hand and Foot Involvement

The Dermatology Digest

Food and Drug Administration (FDA) has updated the label for dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc. and Sanofi), adding efficacy and safety data for people aged 12 years and older with atopic dermatitis (AD) and uncontrolled moderate-to-severe hand and/or foot involvement. and Sanofi report. “We

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Off-label Pearl: Exploring the Role of Narrowband UVB Phototherapy Plus Oral JAK Inhibitors in Vitiligo

The Dermatology Digest

Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now Chronic Hand Eczema 101 Jonathan Silverberg, MD, PhD, MPH Chronic hand eczema (CHE) symptoms can take a dramatic toll on patients’ quality of life. Watch Now The Lowdown on Molluscum Nanette B.

article thumbnail

AD Pipeline Watch: Aslan Reports “Spectacular Results” in Phase 2 Study of Eblasakimab That Included Some Dupilumab-experienced Patients

The Dermatology Digest

Adult atopic dermatitis (AD) patients previously treated with dupilumab (Dupixent, Regeneron and Sanofi) who received 400mg eblasakimab weekly achieved Eczema Area Severity Index (EASI) 90, and 66.7% achieved a Validated Investigator Global Assessment (vIGA) score of 0 or 1 after 16 weeks compared to 14.3%

article thumbnail

Sneak Peek Inside the CSU Treatment Pipeline

The Dermatology Digest

Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now Chronic Hand Eczema 101 Jonathan Silverberg, MD, PhD, MPH Chronic hand eczema (CHE) symptoms can take a dramatic toll on patients’ quality of life. Watch Now The Lowdown on Molluscum Nanette B.

article thumbnail

Think Twice: Is It Really AD?

The Dermatology Digest

Atopic dermatitis (AD) is extremely common, but it can resemble psoriasis, urticaria, non-blistering immunobolus disease, cutaneous lymphoma, and many other skin conditions. Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now The Lowdown on Molluscum Nanette B.

article thumbnail

Isotretinoin: Current Thinking and Best Practices

The Dermatology Digest

Silverberg, MD Molluscum Contagiosum appears to be on the rise and often travels with atopic dermatitis (AD). Watch Now Chronic Hand Eczema 101 Jonathan Silverberg, MD, PhD, MPH Chronic hand eczema (CHE) symptoms can take a dramatic toll on patients’ quality of life. Watch Now The Lowdown on Molluscum Nanette B.